Drugmakers Look to Push Boundaries of Old Age

Google's ambition to defy the limits of aging has fired up interest in the field, drawing in drug companies who are already quietly pioneering research, despite the regulatory and clinical hurdles that remain. In September, life science company Calico, which was set up by Google last year to investigate aging, joined with U.S. drugmaker AbbVie in committing $250 million apiece to developing cures for age-related diseases. Away from the limelight, however, Switzerland's Novartis...

© La Voix de l'Amérique - mercredi 5 novembre 2014